Report #2897293

Received May 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: May 12, 2026
Onset: May 12, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	2	—	—

Symptoms (1)

Expired product administered

Symptom narrative

administration of an expired dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a child patient who received HBV (Engerix B pediatric) (expiry date 20-MAR-2026) for prophylaxis. On 12-MAY-2026, the patient received the 2nd dose of Engerix B pediatric. On 12-MAY-2026, an unknown time after receiving Engerix B pediatric, the patient experienced expired vaccine used (Verbatim: administration of an expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-MAY-2026 The batch number was not provided upon follow up with the reporter.